Six Years for Troubled Xarelto v. Six Decades for Reliable Coumadin

Washington, DC: As we are about a month away from the selection of four bellwether Xarelto trials that are scheduled for early 2017, it’s instructive to compare the rocky road of Xarelto with the longevity of Coumadin (warfarin). The latter had been the gold standard for blood thinning well before the introduction of Xarelto and, before that, Pradaxa. In the short tenure of Xarelto as the currently leading anticoagulant, more than 1,700 plaintiffs have reported a Xarelto Bleeding Issue.